Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-614.93	-78.78	-88.6	-52.7	-	10.87	-25.2	-26.71	-25.17	-14.23	Upgrade
Depreciation & Amortization	2.05	2.51	2.46	2	2.13	1.95	0.5	0.07	0.06	0.04	Upgrade
Share-Based Compensation	14.11	11.95	12.8	1.77	1.1	6.3	2.01	1.72	1.45	1.2	Upgrade
Other Operating Activities	522.01	22.74	0.76	0.82	-29.21	-54.22	4.51	40.09	2.18	-1.6	Upgrade
Operating Cash Flow	-76.76	-41.58	-72.59	-48.11	-25.98	-35.11	-18.18	15.18	-21.48	-14.58	Upgrade
Capital Expenditures	0.1	-0.62	-0.31	-0.42	-0.27	-0.16	-0.45	-0.1	-0.08	-0.04	Upgrade
Acquisitions	-475.02	0	0	0	-0.91	-0.17	-5.97	0	0	0	Upgrade
Change in Investments	-112.86	0	0	0	-	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	0.74	-0.01	-0.13	0	0.04	0.06	Upgrade
Investing Cash Flow	-587.77	-0.62	-0.31	-0.42	-0.44	-0.33	-6.55	-0.1	-0.05	0.02	Upgrade
Share Issuance / Repurchase	111.2	100.29	77.97	50.55	62.5	44.51	19.17	0.49	32.9	27.53	Upgrade
Debt Issued / Paid	-24.69	519.96	-0.05	0	-0.59	0	-0.19	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-1.16	-	-1.79	0.03	-5.23	-2.25	Upgrade
Financing Cash Flow	86.51	620.24	77.92	50.55	60.75	44.51	17.2	0.52	27.67	25.29	Upgrade
Exchange Rate Effect	0.84	-1.22	0.35	0.56	1.43	-2.32	-2.42	-0.9	0.15	0	Upgrade
Net Cash Flow	-577.18	576.82	5.37	2.58	34.33	6.75	-7.53	15.59	6.15	11.54	Upgrade
Free Cash Flow	-76.66	-42.21	-72.89	-48.53	-26.25	-35.26	-18.63	15.08	-21.56	-14.63	Upgrade
Free Cash Flow Margin	-	-5986.67%	-4029.46%	-5643.26%	-	-61.77%	-120.55%	523.44%	-	-	Upgrade
Free Cash Flow Per Share	-0.12	-0.22	-0.55	-0.70	-0.82	-2.06	-1.51	1.23	-1.85	-1.25	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).